Fadi Abdel is a biotech executive and advisor with over three decades of experience in R&D leadership. They are currently the Chief Development & Operations Officer at Speratum Biopharma, where they drive the strategic vision for precision oncology therapies. Fadi has held leadership roles at prominent companies, including Sandoz, Janssen Pharmaceutical, and Novartis, where they successfully advanced therapies through clinical trials and secured numerous regulatory approvals. As a Senior Scientific Board Advisor at Sama Therapeutics, they contribute to the company's innovation in precision neuropsychiatry. Fadi's mission focuses on integrating cutting-edge technology to enhance clinical and business development strategies.
This person is not in the org chart
This person is not in any teams
This person is not in any offices